


{"id":48076,"date":"2023-03-13T13:09:54","date_gmt":"2023-03-13T11:09:54","guid":{"rendered":"https:\/\/newserver.fyb.de\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/"},"modified":"2023-03-15T18:34:39","modified_gmt":"2023-03-15T16:34:39","slug":"add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/","title":{"rendered":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP"},"content":{"rendered":"<p>Frankfurt\/Miami \u2014 Cygna Labs, a leading compli\u00adance and cloud secu\u00adrity soft\u00adware company, has ente\u00adred into a binding agree\u00adment to acquire Vital\u00adQIP, a global DDI soft\u00adware provi\u00adder from Nokia Solu\u00adti\u00adons &amp; Network Oy (\u201cNokia\u201d). Cygna Labs is supported by the Frank\u00adfurt-based private equity firm VR Equi\u00adtyp\u00adart\u00adner (VREP), which holds a mino\u00adrity stake in the company. The acqui\u00adsi\u00adtion includes the Vital\u00adQIP soft\u00adware solu\u00adtion, custo\u00admer base and Vital QIP\u2019s inter\u00adna\u00adtio\u00adnal team of experts.<\/p>\n<p>Cygna Labs is a leading soft\u00adware company in the areas of networ\u00adking, cloud as well as secu\u00adrity and the third largest global DDI provi\u00adder. Many Fortune 100 custo\u00admers use Cygna Labs\u2019 DDI products and services and secu\u00adrity and compli\u00adance solu\u00adti\u00adons to iden\u00adtify and proac\u00adtively miti\u00adgate thre\u00adats to their data secu\u00adrity in a timely manner, pass compli\u00adance audits, and increase the produc\u00adti\u00advity of their IT departments.<\/p>\n<p>Going forward, Cygna Labs\u2019 mana\u00adged service offe\u00adrings will be expan\u00added to include solu\u00adti\u00adons from Vital\u00adQIP, which is one of the top five provi\u00adders of DDI soft\u00adware and has nume\u00adrous deploy\u00adments with large enter\u00adpri\u00adses. Vital\u00adQIP will remain as an inde\u00adpen\u00addent product line within Cygna Labs Group after the tran\u00adsac\u00adtion. As a result of the tran\u00adsac\u00adtion, Vital\u00adQIP custo\u00admers will bene\u00adfit from Cygna Labs\u2019 exper\u00adtise and inno\u00adva\u00adtions, and will conti\u00adnue to be served by compre\u00adhen\u00adsive main\u00adten\u00adance and support services, as well as 24x7 world\u00adwide service.<\/p>\n<p>Alex\u00adan\u00adder H\u00e4cker, CEO of Cygna Labs Group, said, \u201cCygna Labs conti\u00adnues to support large enter\u00adpri\u00adses that rely on our DDI products and services. With this acqui\u00adsi\u00adtion, we expand our offe\u00adring to include Vital\u00adQIP\u2019s indus\u00adtry-proven open and scalable DDI solu\u00adti\u00adons, which we will offer along\u00adside our exis\u00adting DDI solutions.\u201d<\/p>\n<p>\u201cThe acqui\u00adsi\u00adtion of Noki\u00ada\u2019s leading DDI soft\u00adware streng\u00adthens our Intellec\u00adtual Property offe\u00adring and makes Cygna Labs the global number two in the DDI market,\u201d added Chris\u00adtian Ehren\u00adthal, CEO of Cygna Labs. \u201cFrom a busi\u00adness perspec\u00adtive, the acqui\u00adsi\u00adtion expands our product port\u00adfo\u00adlio, adds more Fortune 100 compa\u00adnies to our custo\u00admer base, and increa\u00adses oppor\u00adtu\u00adni\u00adties for Cygna Labs to expand our global market presence.\u201d<\/p>\n<p>Chris\u00adtian Futter\u00adlieb, Mana\u00adging Direc\u00adtor of VR Equi\u00adtyp\u00adart\u00adner, comm\u00adents, \u201cFollo\u00adwing the acqui\u00adsi\u00adti\u00adons of the Diamond IP soft\u00adware solu\u00adtion from British Tele\u00adcom and the DDI busi\u00adness unit of NCC Group last year, the Vital\u00adQIP add-on marks the third important growth step for Cygna Labs within a very short time. We are very plea\u00adsed to be able to accom\u00adpany the company in this process.\u201d<\/p>\n<p><strong>VR Equi\u00adtyp\u00adart\u00adner at a glance<\/strong><\/p>\n<p>VR Equi\u00adtyp\u00adart\u00adner is one of the leading equity finan\u00adciers in Germany, Austria and Switz\u00ader\u00adland. The company supports medium-sized family busi\u00adnesses in a goal-orien\u00adted manner and with deca\u00addes of expe\u00adri\u00adence in the stra\u00adte\u00adgic solu\u00adtion of complex finan\u00adcing issues. Invest\u00adment oppor\u00adtu\u00adni\u00adties include growth and expan\u00adsion finan\u00adcing, corpo\u00adrate succes\u00adsion or share\u00adhol\u00adder chan\u00adges. VR Equi\u00adtyp\u00adart\u00adner offers majo\u00adrity and mino\u00adrity invest\u00adments as well as mezza\u00adnine finan\u00adcing. As a subsi\u00addiary of DZ BANK, the central insti\u00adtu\u00adtion of the coope\u00adra\u00adtive banks in Germany, VR Equi\u00adtyp\u00adart\u00adner consis\u00adt\u00adently puts the sustaina\u00adbi\u00adlity of corpo\u00adrate deve\u00adlo\u00adp\u00adment ahead of short-term exit thin\u00adking. VR Equi\u00adtyp\u00adart\u00adner\u2019s port\u00adfo\u00adlio curr\u00adently compri\u00adses around 60 commit\u00adments with an invest\u00adment volume of EUR 400 million. www.vrep.de.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frankfurt\/Miami \u2014 Cygna Labs, a leading compli\u00adance and cloud secu\u00adrity soft\u00adware company, has ente\u00adred into a binding agree\u00adment to acquire Vital\u00adQIP, a global DDI soft\u00adware provi\u00adder from Nokia Solu\u00adti\u00adons &amp; Network Oy (\u201cNokia\u201d). Cygna Labs is supported by the Fran\u00adk\u00ad\u00adfurt-based private equity firm VR Equi\u00adtyp\u00adart\u00adner (VREP), which holds a mino\u00adrity stake in the company. The&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":48074,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1368,1377],"tags":[],"class_list":["post-48076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-consultants-auditors","category-corporate-finance-ma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Frankfurt\/Miami \u2014 Cygna Labs, a leading compli\u00adance and cloud secu\u00adrity soft\u00adware company, has ente\u00adred into a binding agree\u00adment to acquire Vital\u00adQIP, a global DDI soft\u00adware provi\u00adder from Nokia Solu\u00adti\u00adons &amp; Network Oy (\u201cNokia\u201d). Cygna Labs is supported by the Frank\u00adfurt-based private equity firm VR Equi\u00adtyp\u00adart\u00adner (VREP), which holds a mino\u00adrity stake in the company. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-13T11:09:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-15T16:34:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"840\" \/>\n\t<meta property=\"og:image:height\" content=\"520\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP\",\"datePublished\":\"2023-03-13T11:09:54+00:00\",\"dateModified\":\"2023-03-15T16:34:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\"},\"wordCount\":514,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers, tax consultants, auditors\",\"Corporate Finance\/M&amp;A\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\",\"url\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\",\"name\":\"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg\",\"datePublished\":\"2023-03-13T11:09:54+00:00\",\"dateModified\":\"2023-03-15T16:34:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg\",\"width\":840,\"height\":520},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/","og_locale":"en_US","og_type":"article","og_title":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook","og_description":"Frankfurt\/Miami \u2014 Cygna Labs, a leading compli\u00adance and cloud secu\u00adrity soft\u00adware company, has ente\u00adred into a binding agree\u00adment to acquire Vital\u00adQIP, a global DDI soft\u00adware provi\u00adder from Nokia Solu\u00adti\u00adons &amp; Network Oy (\u201cNokia\u201d). Cygna Labs is supported by the Frank\u00adfurt-based private equity firm VR Equi\u00adtyp\u00adart\u00adner (VREP), which holds a mino\u00adrity stake in the company. The [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2023-03-13T11:09:54+00:00","article_modified_time":"2023-03-15T16:34:39+00:00","og_image":[{"width":840,"height":520,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP","datePublished":"2023-03-13T11:09:54+00:00","dateModified":"2023-03-15T16:34:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/"},"wordCount":514,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg","articleSection":["General","Featured","Private equity","News","Lawyers, tax consultants, auditors","Corporate Finance\/M&amp;A"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/","url":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/","name":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg","datePublished":"2023-03-13T11:09:54+00:00","dateModified":"2023-03-15T16:34:39+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/03\/cygny-lab-unternehmensseite.jpg","width":840,"height":520},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/add-on-vr-equitypartner-supports-cygna-labs-in-acquisition-of-vitalqip\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Add-on: VR Equity supports Cygna Labs in acquisition of VitalQIP"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/48076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=48076"}],"version-history":[{"count":1,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/48076\/revisions"}],"predecessor-version":[{"id":48094,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/48076\/revisions\/48094"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/48074"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=48076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=48076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=48076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}